Posted by Michael Wonder on 26 May 2020
ICER releases draft evidence report on ulcerative colitis therapies
26 May 2020 - Public comment period now open until 29 July 2020; requests to make oral comment during public meeting also being accepted.
The Institute for Clinical and Economic Review (ICER) today released a Draft Evidence Report assessing the comparative clinical effectiveness and value of treatments for ulcerative colitis.
This preliminary draft marks the midpoint of ICER’s process of assessing these treatments, and the findings within this document should not be interpreted to be ICER’s final conclusions.
